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Abstract
OBJECTIVES: Minimally invasive surgical techniques with optimal outcomes are of paramount importance. Sutureless and rapid deploy-
ment aortic valves are increasingly implanted via minimally invasive approaches. We aimed to analyse the procedural outcomes of a full
sternotomy (FS) compared with those of minimally invasive cardiac surgery (MICS) and further assess MICS, namely ministernotomy (MS)
and anterior right thoracotomy (ART).
METHODS: We selected all isolated aortic valve replacements in the Sutureless and Rapid Deployment Aortic Valve Replacement
International Registry (SURD-IR, n = 2257) and performed propensity score matching to compare aortic valve replacement through FS or
MICS (n = 508/group) as well as through MS and ART accesses (n = 569/group).
RESULTS: Postoperative mortality was 1.6% in FS and MICS patients who had a mean logistic EuroSCORE of 11%. Cross-clamp and cardio-
pulmonary bypass (CPB) times were shorter in the FS group than in the MICS group (mean difference 3.2 and 9.2 min; P < 0.001). Patients
undergoing FS had a higher rate of acute kidney injury (5.6% vs 2.8%; P = 0.012). Direct comparison of MS and ART revealed longer mean
cross-clamp and CPB times (12 and 16.7 min) in the ART group (P < 0.001). The postoperative outcome revealed a higher stroke rate (3.2%
vs 1.2%; P = 0.043) as well as a longer postoperative intensive care unit [2 (1–3) vs 1 (1–3) days; P = 0.009] and hospital stay [11 (8–16) vs 8
(7–12) days; P < 0.001] in the MS group than in the ART group.
CONCLUSIONS: According to this non-randomized international registry, FS resulted in a higher rate of acute kidney injury. The ART ac-
cess showed a lower stroke rate than MS and a shorter hospital stay than all other accesses. All these findings may be related to underlying
patient risk factors.
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ABBREVIATIONS
ART Anterior right thoracotomy
AVR Aortic valve replacement
CPB Cardiopulmonary bypass
FS Full sternotomy
ICU Intensive care unit
IVSSG International Valvular Surgery Study Group
MICS Minimally invasive cardiac surgery
MS Ministernotomy
PS Propensity score
SURD-IR Sutureless and Rapid Deployment Aortic Valve
Replacement International Registry
TAVI Transcatheter aortic valve implantation
INTRODUCTION
Rapid deployment and sutureless valves were developed to facili-
tate and increase the speed of surgical aortic valve replacement
(AVR) [1]. These valves are also well suited to facilitate minimally
invasive procedures [2–4]. Currently, 2 main minimally invasive
approaches are performed. Ministernotomy (MS) and anterior
right thoracotomy (ART) are increasingly applied to reduce the
trauma of isolated AVR. MS involves splitting the upper half of
the sternum while leaving the caudal part intact [5]. This tech-
nique is easily adapted from full sternotomy (FS) and allows cen-
tral cannulation. The surgical steps for AVR are very similar to
those performed through FS. ART accesses the aortic valve via
the 2nd or 3rd intercostal space [6]. This approach leaves the
sternum intact and thereby considerably reduces surgical trauma.
However, cannulation and aortic valve implantation with sutures
are more demanding. Previous reports and meta-analyses have
compared FS to MS and ART with reassuring results for minimally
invasive procedures [7, 8]. However, most of the procedures
reported in previous analyses were performed with conventional
aortic valves. Outcome data of minimally invasive procedures
with sutureless and rapid deployment valves in a large patient
population targeting the comparison of types of surgical access
have not been reported thus far. Specifically, differences regard-
ing MS and ART have not been intensively discussed. While sev-
eral centres have reported excellent results with the ART
procedure, 1 centre reported an increased rate of complications
with ART compared to FS [9–12]. Therefore, we compared the
outcome of surgical AVR through these 2 minimally invasive
approaches with data from the currently largest registry for
sutureless and rapid deployment valves, the Sutureless and Rapid
Deployment Aortic Valve Replacement International Registry
(SURD-IR) [13]. This analysis includes all minimally invasive AVRs
that were performed and reported in this registry.
PATIENTS AND METHODS
Patients
The International Valvular Surgery Study Group (IVSSG) consists
of 18 clinical centres in Europe, Australia and Canada, and it
established the SURD-IR in 2015 [13]. All patients included in
the registry were from one of the participating centres of the
IVSSG. The SURD-IR aims to evaluate the current management
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and outcomes of surgery with sutureless and rapid deployment
valves.
The clinical centres were selected according to their experi-
ence with sutureless and rapid deployment aortic valves, defined
by more than 50 cases or specific recommendations by the
IVSSG Research Steering Committee [14]. The project was sub-
mitted and approved by the local ethics committees. Data were
sent for centralized reporting. The requested data consisted of
155 variables, including demographics, patient comorbidities,
functional status, imaging studies, surgical data, postoperative
course and clinical and haemodynamic outcomes. Valve-related
adverse events were collected and reported according to the cur-
rent guidelines [15]. Clinically important absent data were
queried with the submitting centre. Submitted clinical data were
analysed for validity and compared to previously published data.
All patients in this registry undergoing isolated AVR via a min-
imally invasive (either via MS or ART) or FS approach and who
received a currently available sutureless or rapid deployment
valve [Perceval S (Livanova PLC, London, UK) or the EDWARDS
INTUITY/INTUITY Elite (Edwards Lifesciences, Irvine, CA, USA)]
were included in the present analysis. Databank closure occurred
in November 2018.
Statistical analysis
Continuous variables were expressed as the mean ± standard de-
viation, and categorical variables were expressed as percentages.
When continuous variables did not follow a normal distribution
(tested using the Kolmogorov–Smirnov test for normality and Q–
Q plots), the median and interquartile range were reported.
Percentages were calculated with the available data as the
denominator.
Categorical variables were compared with the v2 test.
Normally distributed continuous data were compared with un-
paired t-tests or one-way analysis of variance as appropriate.
Further specifications regarding missing data and propensity
matching are provided in the Supplementary Material. A P-value
of 0.05 was considered significant. The SPSS 25.0 statistical
software package (SPSS, Chicago, IL, USA) was used for statistical
calculations.
RESULTS
A total of 1111 patients underwent MS (37% male), 627 patients
underwent ART (39% male), and 529 patients underwent surgery
via FS (21% male). Surgical access varied significantly between
centres according to institutional practice, and the surgeon’s ex-
perience and preference (Fig. 1). After propensity score (PS)
matching, 508 patients undergoing minimally invasive surgery
were compared to 508 patients undergoing FS, and 569 patients
undergoing ART were compared to 569 patients undergoing MS.
Full sternotomy versus minimally invasive aortic
valve replacement
The baseline patient characteristics before and after PS are
reported in Table 1. The surgical access in the minimally invasive
cohort was MS in 69% and ART in 31%. The valve types were not
different between the groups. Cross-clamp and cardiopulmonary
bypass (CPB) times were significantly shorter in the FS group
than in the minimally invasive cardiac surgery (MICS) group, with
a mean difference of 3.2 min for cross-clamp time and 9.2 min
for CPB time (Table 2). In-hospital mortality was 1.6% for both
groups. Pacemaker implantation was required in 10% (MICS) and
9.1% (FS), which was not different between the groups. Other in-
hospital outcomes were also similar, but patients undergoing FS
had a higher rate of acute kidney injury and dialysis than patients
undergoing MICS (Table 3).
Anterior right thoracotomy versus ministernotomy
surgical access
Before PS matching, patients in the MS group were in a higher
New York Heart Association functional class, had a higher body
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mass index, and had a higher rate of atrial fibrillation, pulmon-
ary hypertension and renal insufficiency than those of patients
in the ART group (P < 0.01). The patient baseline characteristics
after matching are reported in Table 4. Patients undergoing the
ART procedure were significantly more likely to receive a
Perceval S valve than patients undergoing MS (87.7 vs 67.6%;
P < 0.001). No differences were found regarding valve malposi-
tioning or conversion to FS (Table 5). However, the mean
cross-clamp time was 12 min longer and the mean CBP time
was 16.7 min longer in the ART group than those in the MS
group (P < 0.001, Table 5). Postoperative outcomes revealed a
higher stroke rate and a longer postoperative intensive care
unit (ICU) and hospital stay in the MS group than those in the
ART group (Table 6). Pacemaker implantation was required in
8.5% (ART) and 9.9% (MS), and mild postoperative aortic regur-
gitation occurred in 6% (ART) and 8.2% (MS); both were not
different between the groups.
DISCUSSION
This analysis of SURD-IR data reports the access-specific out-
comes for isolated AVR with sutureless and rapid deployment
aortic valves. While the outcomes for all access types were com-
parable regarding low perioperative mortality, patients under-
going FS had a higher rate of acute kidney injury than those
undergoing MICS, and patients undergoing MS had a higher
stroke rate than those undergoing ART. ART patients had a
shorter hospital stay than MS patients.
Minimally invasive AVR has previously been described to be
associated with reduced postoperative complications, reduced
hospital stay and increased patient satisfaction [7, 8, 11]. This pro-
cedure may improve patient satisfaction and acceptance. A po-
tential drawback of minimally invasive access is the inability to
treat concomitant pathologies such as atrial fibrillation. The ac-
cess should therefore be discussed in detail with the patient prior
to surgery if the patient is an eligible candidate for a maze pro-
cedure. Furthermore, the observed increased rate of postopera-
tive kidney injury was not seen in other reports and cannot be
attributed to the surgical access alone due to the non-
randomized study design [10].
We report on the largest contemporary cohort comparing the
2 most relevant minimally invasive techniques for AVR with rapid
deployment or sutureless prostheses [13]. The present results re-
flect the real-world experience with these valves in expert and
high-volume centres as well as the learning curve with these new
valves. The percentage of patients receiving either MS or ART
was different between study centres, which may also account for
some of the observed differences (Fig. 1). Overall mortality was
low compared to the preoperative surgical risk (1.6% for a logis-
tical EuroSCORE of 11%). As expected, CPB and cross-clamp
times were prolonged in patients who underwent a minimally in-
vasive access compared with patients who underwent FS, and
within this group, ART patients had the longest perfusion times
Table 1: Patient characteristics (MICS vs FS)
Characteristics Overall cohort Propensity-matched cohort
MICS (n = 1738) FS (n = 529) Standardized
differencea
MICS (n = 508) FS (n = 508) Standardized
differencea
Male gender 37.9 33.6 8.4 35.6 34.1 3.2
Age (years), mean (SD) 76 (6.7) 77.7 (7.3) -26 77.4 (6.7) 77.5 (7.3) -2.1
NYHA class
I 6.2 4.5 8.5 3.5 4.9 -4.6
II 46.3 30.7 32.6 36 31.3 9.1
III 44.6 57.7 -29.3 54.4 57.4 -7.9
IV 2.9 7.1 -20.7 6.1 6.4 -2.3
Hypertension 81.1 82.4 -2.7 83.3 82.5 3
Obesity 27.3 25.1 3.6 25.2 26 2.6
BMI (kg/m2), mean (SD) 27.5 (4.9) 27.2 (4.9) 3.2 27.1 (4.9) 27.3 (5) -2.1
Diabetes 28.4 28.9 -2.9 27.8 29.3 -3.5
Atrial fibrillation 12.4 17.5 -13.8 16.3 16.9 -1.6
PM 2.8 6 -18.8 2.8 5.5 -18.4
Surgical indications -7 0
Aortic valve stenosis 62.6 75.8 -27.1 71.6 75.4 -4.2
Aortic valve regurgitation 1.3 0.4 7.6 0.8 0.4 3.6
Mixed aortic valve disease 36.1 23.8 26.5 27.6 24.2 7.1
Pulmonary hypertension 22.8 39.5 -32.1 32.5 34.8 -1.4
Cerebrovascular disease 10.9 9.3 4.6 10 9.4 0.6
Renal insufficiency 42.6 51.4 -14.8 48.3 51.7 -6.8
Chronic lung disease 15.1 14.9 2.1 15 15.4 -4.2
LVEF%, mean (SD) 58.6 (9.3) 58.3 (12.2) 4.9 59.1 (10) 58.5 (11.9) 8.3
LVEF >50 83.6 78.8 83.2 79.3
LVEF 30–50 15.5 17.7 15.2 17.1
LVEF <30 0.9 3.5 1.6 3.5
Logistic EuroSCORE (%), mean (SD) 8.9 (6.4) 11.8 (9.7) -46.3 10.7 (8.5) 11 (8.6) -7.4
Values are percentages unless otherwise indicated.
aStandardized difference is the mean difference divided by the pooled SD, expressed as a percentage.
BMI: body mass index; FS: full sternotomy; LVEF: left ventricular ejection fraction; MICS: minimally invasive cardiac surgery; NYHA: New York Heart Association;
PM: pacemaker; SD: standard deviation.
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[10, 11]. However, cross-clamp times were expected to be signifi-
cantly shorter with these valves compared to conventional valves
with the same access. Borger et al. [16] showed reduced cross-
clamp times for rapid deployment valves in a randomized trial.
Furthermore, studies analysing ART access with conventional
valves showed higher cross-clamp times compared to the data
from our registry [12, 17]. MS patients had a higher rate of post-
operative stroke than that of ART patients. In addition, ART
patients had a shorter postoperative ICU and hospital stay than
MS patients, which has been previously described [17]. The
observed differences between the access groups can be partially
explained by the access itself but may also be related to a higher
level of experience of the operating surgeons or specific patient
selection not adjusted by PS matching. We additionally analysed
the stroke rate for the complete matched cohort according to
valve type to exclude an effect of unequally distributed valve
types in the ART and MS groups, but valve type was not associ-
ated with a significantly different stroke rate (stroke rate: Perceval
2.5%, Intuity 1.1%; P = 0.23). Although this was not a randomized
study, ART access appeared to be at least as safe as MS and FS.
However, specialized centres performed the procedures in this
registry, and outcome data may vary according to the centre’s
experience.
Chang et al. [10] recently performed a meta-analysis of 19
studies including >10 000 patients to evaluate the outcomes of
MS and ART compared to each other and to conventional
AVR. However, no information regarding the use of sutureless
or rapid deployment aortic valves was provided. Minimally in-
vasive aortic valve surgery led to a reduced postoperative stay,
which was more pronounced after the ART procedure than
after MS. This finding was confirmed by our results for suture-
less and rapid deployment aortic valves and is in line with
Table 2: Operative data (MICS vs FS)
Overall cohort Propensity-matched cohort
MICS (n = 1738) FS (n = 529) P-value MICS (n = 508) FS (n = 508) P-value
Valve type 0.16 0.12
Perceval S 75.9 79 74.4 78.7
Intuity/Intuity Elite 24.1 21 25.6 21.3
Valve malpositioning 1 0.3 0.37 0.6 0.3 0.91
ART 36.1 31.1
MS 63.9 68.9
Conversion to FS 1 0.6
CPB time (min), mean (SD) 79.4 (30) 69.2 (33.4) <0.001 78.0 (27.4) 68.8 (33.4) <0.001
Clamp time (min), mean (SD) 50.2 (21.1) 45.7 (23) <0.001 48.8 (18.9) 45.6 (22.8) <0.001
Values are percentages unless otherwise indicated.
ART: anterior right thoracotomy; CPB: cardiopulmonary bypass; FS: full sternotomy; MICS: minimally invasive cardiac surgery; MS: ministernotomy; SD: standard
deviation.
Table 3: In-hospital outcomes (MICS vs FS)
Overall cohort Propensity-matched cohort
MICS (n = 1738) FS (n = 529) P-value MICS (n = 508) FS (n = 508) P-value
In-hospital mortality 1.4 1.6 0.84 1.6 1.6 1
Stroke 2.4 1.2 0.21 2.1 1.2 0.41
Low cardiac output 0.9 0.5 0.86 1.1 0.5 0.66
Ventilatory support >72 h 3 3 1 3.1 3.1 1
New-onset AF 27.7 28.4 0.76 26.6 28.3 0.59
PM implantation 9.4 8.4 0.78 10 9.1 0.71
Aortic regurgitation 0.007 0.11
Mild 7.1 12.7 7.8 12.4
Moderate 1 1.4 1.2 1.4
Severe 0.2 0.6
Bleeding 4.1 3.5 0.86 3.9 3.2 0.83
AKI (>stage 1) 3 5.4 0.029 2.8 5.6 0.012
Dialysis 1.3 4.2 0.006 1.5 4.3 0.04
Wound complications 3.5 3.1 0.97 3.1 3.2 0.99
Peak gradient (mmHg), mean (SD) 25.9 (10.3) 24.1 (9) 0.005 25.2 (9.7) 24.1 (8.9) 0.17
Mean gradient (mmHg), mean (SD) 13.7 (5.8) 13.1 (5.4) 0.052 13.6 (5.9) 13.1 (5.4) 0.27
ICU stay (days), median (IQR) 1 (1–3) 1 (1–3) 0.16 1 (1–3) 1 (1–3) 0.10
Hospital stay (days), median (IQR) 8 (7–12) 9 (7–13) 0.76 8 (7–12) 9 (7–14) 0.65
Values are percentages unless otherwise indicated.
AF: atrial fibrillation; AKI: acute kidney injury; FS: full sternotomy; ICU: intensive care unit; IQR: interquartile range; MICS: minimally invasive cardiac surgery; PM:
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other reports [18]. Balmforth et al. showed a comparable mor-
tality and stroke rate between MS and ART, but ART had a
reduced rate of postoperative atrial fibrillation. We were able
to confirm similar mortality between groups and a trend to-
wards a reduced rate of postoperative atrial fibrillation, but we
observed a higher stroke rate in the MS group than in the ART
group. This worrying observation is unlikely to be related to
surgical access but needs further investigation. The rate of atrial
fibrillation and the number of patients with aortic stenosis were
numerically higher in the MS group than in the ART group
after propensity matching, which might also have contributed
to these findings.
Recent results of the Partner 3 and the EvolutR Low-Risk trials
suggest the extension of transcatheter aortic valve implantation
(TAVI) to low-risk patients [19, 20]. However, this option should
be considered carefully due to the associated risks, the selective
inclusion criteria for these trials and the currently unknown long-
term durability. Nevertheless, surgical programmes have to adapt
Table 4: Patient characteristics (ART vs MS)
Characteristics Overall cohort Propensity-matched cohort
ART (n = 627) MS (n = 1111) Standardized
differencea
ART (n = 569) MS (n = 569) Standardized
differencea
Male gender 39.1 37.3 3.7 38.5 38.3 0.4
Age (years), mean (SD) 75.5 (7.1) 76.3 (6.5) -10.5 75.8 (6.8) 75.9 (6.5) -1.5
NYHA class
I 4.2 7.1 -6.5 5.1 6 -2.1
II 55 41 32.5 51.3 48.7 5.3
III 39.4 48 -21.8 40.6 41.8 -2.5
IV 1.3 3.9 -18.8 1.2 1.8 -5
Hypertension 79.5 82.3 -7 79.3 79.4 -0.4
Obesity 23.4 29.7 -15.6 25 24.8 0.4
BMI (kg/m2), mean (SD) 27 (4.5) 27.7 (5.1) -11.2 27.2 (4.6) 27.3 (4.7) -1.1
Diabetes 25.7 29.6 -10.3 26.7 27.4 -1.6
Atrial fibrillation 7.2 14.4 -24.2 8.3 9.5 -4.6
PM 2.8 2.8 0.0 2.8 2.1 6.4
Surgical indications
Aortic valve stenosis 45.4 71.4 -49.7 50.5 54.1 -6.3
Aortic valve regurgitation 0.6 1.4 -11.2 0.7 0.7 0
Mixed aortic valve disease 53.8 27.3 53.5 48.9 45.2 7.7
Pulmonary hypertension 19.4 25.3 -12.9 19.7 21.1 -3.6
Cerebrovascular disease 10 10.8 -2.5 11.7 10.5 6.5
Renal insufficiency 36.1 45 -22.4 38.1 41.3 -4.4
Chronic lung disease 17.2 13.8 9.8 16.2 14.1 6.4
LVEF%, mean (SD) 57.9 (8.3) 59 (9.8) -14.7 58 (8.4) 57.9 (9.7) 1.1
LVEF >50 84.8 83.2 85.2 82.3
LVEF 30–50 14.4 15.8 14.1 17
LVEF <30 0.6 1 0.7 0.7
Logistic EuroSCORE (%), mean (SD) 8.6 (6.1) 9.1 (6.6) -10.6 8.7 (6.3) 9 (6.3) -3.9
Values are percentages unless otherwise indicated.
aStandardized difference is the mean difference divided by the pooled SD, expressed as a percentage.
ART: anterior right thoracotomy; BMI: body mass index; LVEF: left ventricular ejection fraction; MS: ministernotomy; NYHA: New York Heart Association; PM:
pacemaker; SD: standard deviation.
Table 5: Operative data (ART vs MS)
Overall cohort Propensity-matched cohort
ART (n = 627) MS (n = 1111) P-value ART (n = 569) MS (n = 569) P-value
Valve type <0.001 <0.001
Perceval S 87.6 69.3 87.7 67.6
Intuity/Intuity Elite 12.4 30.7 12.3 32.4
Valve malpositioning 1.9 0.9 0.23 2 0.8 0.35
Conversion to FS 1 0.9 0.99 0.8 1.2 0.49
CPB time (min), mean (SD) 90.9 (33) 72.8 (26) <0.001 90.3 (34) 73.6 (25.7) <0.001
Clamp time (min), mean (SD) 58.7 (23.7) 45.4 (17.5) <0.001 58.1 (23.9) 46.1 (17.5) <0.001
Values are percentages unless otherwise indicated.
ART: anterior right thoracotomy; CPB: cardiopulmonary bypass; FS: full sternotomy; MS: ministernotomy; SD: standard deviation.
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and offer minimally invasive alternatives to FS with excellent
results. However, this strategy is still slowly developing, and sev-
eral centres do not offer these techniques [21]. Rapid deployment
and sutureless aortic valves have the ability to facilitate minimally
invasive surgery and are therefore an excellent adjunct to support
the required changes in surgical practice [2, 22, 23]. We were
able to show improved laminar flow for the Edwards Intuity
valve, which opens the left ventricular outflow tract with the stent
part of the valve [24]. This reduces transvalvular gradients and
may be a relevant factor contributing to the excellent long-term
survival in this patient population [3, 23, 25, 26]. This is also a
very important argument in the current discussion regarding the
low-risk patient population, as the recent Partner 3 trial revealed
higher gradients in the TAVI cohort than that in the surgical com-
parator [19]. Lower gradients are essential to reduce the risk of
prosthesis-patient mismatch, which may adversely influence
long-term survival. Long-term durability data are currently not
available for sutureless and rapid deployment valves, but no
increased rate of reoperation has been observed so far.
Therefore, it seems appropriate to also discuss the prospect of
valve-in-valve procedures for sutureless and rapid deployment
aortic valves. These valves are well-suited targets for potential
valve-in-valve procedures, which is not true for every other cur-
rently available standard surgical prosthesis [27]. Postoperative
conduction disturbances are still a matter of concern following
sutureless and rapid deployment AVR [13, 25]. This may also pre-
sent a potential issue for younger patients, who would require a
permanent pacemaker. However, we reported a relevant risk re-
duction of 5.6% in the most recent cohort due to growing surgi-
cal experience, which was also shown in the current report for
minimally invasive approaches [3]. Furthermore, a recent analysis
of conduction disturbances after rapid deployment aortic valves
revealed preoperative right bundle branch block as a strong risk
factor for pacemaker implantation [28]. Therefore, improved
patient selection for these specific valves may further reduce the
pacemaker implantation rate.
Limitations
This study has the limitations of any observational registry
involving no adjudication of patient inclusion and data collec-
tion. Because of the retrospective nature of the registry, there
was no core laboratory to review images, and the investigators
were responsible for data reporting from their own institutions.
A majority of the participating institutions might have a poten-
tial bias as the surgeons participated in first-in-man and CE
market studies. Propensity analysis is a powerful statistical tech-
nique, but it is limited by the number and accuracy of the
assessed variables. However, it is worth noting that in our ana-
lysis, a considerable number of plausible preoperative and intra-
operative covariates were used to compute the PS, and the
post-matching covariate balance was excellent. Long-term sur-
vival is currently not sufficiently recorded to include these data
in the article.
CONCLUSIONS
According to this non-randomized international registry, FS
resulted in a higher rate of acute kidney injury. Patient with an
ART access had a lower stroke rate than those with MS, and a
shorter hospital stay than those with all other accesses. All these
findings may be related to underlying patient risk factors.
SUPPLEMENTARY MATERIAL
Supplementary material is available at EJCTS online.
Table 6: In-hospital outcomes (ART vs MS)
Overall cohort Propensity-matched cohort
ART (n = 627) MS (n = 1111) P-value ART (n = 569) MS (n = 569) P-value
In-hospital mortality 0.7 1.8 0.19 0.9 1.4 0.58
Stroke 1.1 3.1 0.023 1.2 3.2 0.043
Low cardiac output 0.2 1.4 0.041 0.4 1.4 0.11
Ventilatory support >72 h 1.9 3.6 0.14 1.8 3.2 0.18
New-onset AF 25.9 28.6 0.52 25.1 30.2 0.088
PM implantation 7.3 9.9 0.31 8.5 9.9 0.67
Aortic regurgitation 0.41 0.41
Mild 5.7 7.3 6 8.2
Moderate 1.2 0.7
Severe 0.2
Bleeding 3.8 4.2 0.83 3 4.4 0.27
AKI (>stage 1) 2.1 3.5 0.049 2.1 2.8 0.57
Dialysis 0.9 1.5 0.006 0.7 1.5 0.033
Wound complications 3.9 3.3 0.83 4.4 4 0.86
Peak gradient (mmHg), mean (SD) 24.6 (8.1) 26.3 (10.8) 0.061 24.1 (9.3) 25.2 (10.7) 0.063
Mean gradient (mmHg), mean (SD) 13.9 (5.3) 13.7 (5.9) 0.13 13.5 (5.5) 13.4 (5.8) 0.89
ICU stay (days), median (IQR) 1 (1–2) 2 (1–3) <0.001 1 (1–3) 2 (1–3) 0.009
Hospital stay (days), median (IQR) 8 (7–12) 10 (8–15) 0.001 8 (7–12) 11 (8–16) <0.001
Values are percentages unless otherwise indicated.































niversitaetsbibliothek Bern user on 14 D
ecem
ber 2020
Conflict of interest: Martin Andreas is a proctor (Edwards,
Abbott) and advisory board member (Medtronic), Emmanuel
Villa is a proctor (LivaNova) and Theodor Fischlein is a consultant
(LivaNova and BioStable). All other authors declared no conflict
of interest.
Author contributions
Martin Andreas: Conceptualization; Data curation; Investigation;
Methodology; Supervision; Validation; Visualization; Writing—original draft;
Writing—review & editing. Paolo Berretta: Conceptualization; Data curation;
Formal analysis; Investigation; Methodology; Project administration;
Resources; Supervision; Validation; Visualization; Writing—original draft;
Writing—review & editing. Marco Solinas: Conceptualization; Data curation;
Investigation; Methodology; Supervision; Validation; Writing—review & edit-
ing. Giuseppe Santarpino: Conceptualization; Data curation; Investigation;
Methodology; Supervision; Validation; Writing—review & editing. Utz
Kappert: Conceptualization; Data curation; Investigation; Methodology;
Supervision; Validation; Writing—review & editing. Antonio Fiore:
Conceptualization; Data curation; Investigation; Methodology; Supervision;
Validation; Writing—review & editing. Mattia Glauber: Conceptualization;
Data curation; Investigation; Methodology; Supervision; Validation; Writing—
review & editing. Martin Misfeld: Conceptualization; Data curation;
Investigation; Methodology; Supervision; Validation; Writing—review & edit-
ing. Carlo Savini: Conceptualization; Data curation; Investigation;
Methodology; Supervision; Validation; Writing—review & editing. Elisa Mikus:
Conceptualization; Data curation; Investigation; Methodology; Supervision;
Validation; Writing—review & editing. Emmanuel Villa: Conceptualization;
Data curation; Investigation; Methodology; Supervision; Validation; Writing—
review & editing. Kevin Phan: Conceptualization; Data curation;
Investigation; Methodology; Supervision; Validation; Writing—review & edit-
ing. Theodor Fischlein: Conceptualization; Data curation; Investigation;
Methodology; Supervision; Validation; Writing—review & editing. Bart
Meuris: Conceptualization; Data curation; Investigation; Methodology;
Supervision; Validation; Writing—review & editing. Gianluca Martinelli:
Conceptualization; Data curation; Investigation; Methodology; Supervision;
Validation; Writing—review & editing. Kevin Teoh: Conceptualization; Data
curation; Investigation; Methodology; Supervision; Validation; Writing—review
& editing. Carmelo Mignosa: Conceptualization; Data curation; Investigation;
Methodology; Supervision; Validation; Writing—review & editing. Malakh
Shrestha: Conceptualization; Data curation; Investigation; Methodology;
Supervision; Validation; Writing—review & editing. Thierry P. Carrel:
Conceptualization; Data curation; Investigation; Methodology; Supervision;
Validation; Writing—review & editing. Tristan Yan: Conceptualization; Data
curation; Investigation; Methodology; Supervision; Validation; Writing—review
& editing. Guenther Laufer: Conceptualization; Data curation; Investigation;
Methodology; Supervision; Validation; Writing—review & editing. Marco Di
Eusanio: Conceptualization; Data curation; Formal analysis; Investigation;
Methodology; Project administration; Resources; Supervision; Validation;
Writing—review & editing.
Reviewer information
European Journal of Cardio-Thoracic Surgery thanks David Schibilsky and the
other, anonymous reviewer(s) for their contribution to the peer review pro-
cess of this article.
REFERENCES
[1] Miceli A, Santarpino G, Pfeiffer S, Murzi M, Gilmanov D, Concistre G
et al. Minimally invasive aortic valve replacement with Perceval S suture-
less valve: early outcomes and one-year survival from two European
centers. J Thorac Cardiovasc Surg 2014;148:2838–43.
[2] Andreas M, Wallner S, Habertheuer A, Rath C, Schauperl M, Binder T et al.
Conventional versus rapid-deployment aortic valve replacement: a single-
centre comparison between the Edwards Magna valve and its rapid-
deployment successor. Interact CardioVasc Thorac Surg 2016;22:799–805.
[3] Berretta P, Andreas M, Carrel TP, Solinas M, Teoh K, Fischlein T et al.
Minimally invasive aortic valve replacement with sutureless and rapid
deployment valves: a report from an international registry (Sutureless
and Rapid Deployment International Registry). Eur J Cardiothorac Surg
2019;56:793–9.
[4] Laborde F, Fischlein T, Hakim-Meibodi K, Misfeld M, Carrel T, Zembala
M et al. Clinical and haemodynamic outcomes in 658 patients receiving
the Perceval sutureless aortic valve: early results from a prospective
European multicentre study (the Cavalier Trial). Eur J Cardiothorac Surg
2016;49:978–86.
[5] Kocher A, Coti I, Laufer G, Andreas M. Minimally invasive aortic valve re-
placement through an upper hemisternotomy: the Vienna technique.
Eur J Cardiothorac Surg 2018;53:ii29–31.
[6] Andreas M, Mahr S, Kocher A, Laufer G. Minimalinvasiver
Aortenklappenersatz über eine anteriore rechtsseitige Thorakotomie. Z
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